A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms

NCT01387763 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

202

Enrollment

OTHER

Sponsor class

Conditions

Polycythemia Vera
Essential Thrombocythemia
Primary Myelofibrosis

Interventions

DRUG: PegIntron
DRUG: Pegasys
DRUG: PegIntron
DRUG: Pegasys
DRUG: Hydrea

Sponsor

Thomas Stauffer Larsen